http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
1990 년대 한국 성인에서 역류성 식도염의 유병률 변화
정성애(Sung Ae Jung),정훈용(Hwoon Yong Jung),김기락(Ki Rhack Kim),민영일(Young Il Min) 대한소화기기능성질환·운동학회 2001 Journal of Neurogastroenterology and Motility (JNM Vol.7 No.2
N/A Backgroud/Aims: The prevalence of reflux esophagitis has been considered to be low in Korea, but recent studies suggested that it has been increasing. The prevalence also is generally thought to be less in Korea compared to that in western countries. Methods: Data was collected from the leading medical journals published in Korea dealing with the prevalence of reflux esophagitis for last 10 years between 1990 and 1999 and annual reports of Health Promotion Center in Asan Medical Center of 1997 to 1999. Results: The prevalence was occupied 1.3% in the early period of 1990's, 5.3% in the middle and 7.2% in the late period in symptomatic group and 2.7%, 3.2% and 5.8% in asymptomatic group. The prevalence was reported 5.4% in 1997, 5.3% in 1998 and 7.0% in 1999 in asymptomatic group of annual report of Health Promotion Center in Asan Medical Center. Associated conditions in reflux esophagitis were hiatal hernia, alcohol consumption, smoking and obesity suggesting as risk factors. Conclusions: The prevalence of reflux esophagitis in Korea has increased in last 10 years of 1990' s but is still lower than that in the western countries. Continuous increase in the prevalence of reflux esophagitis in Korea is predictable and it leads to a greater concern for accurate diagnosis and rapid treatment of symptoms. (Korean Journal of Gastrointestinal Motility 2001;7:161-167 )
정성애 ( Sung Ae Jung ) 대한소화기기능성질환·운동학회 2004 Journal of Neurogastroenterology and Motility (JNM Vol.10 No.2
요약: 위장관에 대한 oxytocin의 효과는 뚜렷하지 않다. 이 연구는 oxytocin을 주입하였을 때 여성의 대장 운동성 및 감수성을 알아보기 위한 것이다. 14명의 건강한 여성을 대상으로 각각 2주 간격으로 2회 실험하였다. 6개의 채널을 가지고 barostat 풍선에서부터 근위부로 2㎝ 간격의 3개의 측정점이 있고, 풍선에서부터 말단부로 3개의 측정점을 가진 perfusion catheter를 대장의 비장 만곡부까지 삽입하였다. 위-대장 반사의
최신 연구 소개 : 혈청에 존재하는 Galectin-3 Ligand는 Haptoglobin 관련 당단백질로 대장암 환자에서 증가한다
정성애 ( Sung Ae Jung ) 대한소화기학회 2005 대한소화기학회지 Vol.45 No.4
Galectin-3는 정상이나 종양조직에 존재하는 galactose 결합단백질로 세포의 결합이나 성장을 조절하는 데 관여한다. 대장암조직에서 galectin-3는 종양의 병기, 예후, 전이와 관련이 있으며, 혈청 galectin-3도 정상인에 비해 소화기계 종양환자에서 증가한다. 대장암세포주에 존재하는 ligand 중 Mac-2 결합 당단백질, CEA, lamp-1, lamp-2 당단백질이 있으며, 대장암에 존재하는 mu-cin이 galectin-3 l
대장의 점막하 침윤암의 심달도와 림프절 전이에 따른 기질단백분해효소와 억제인자의 발현 및 신생혈관 형성
정성애 ( Sung Ae Jung ),양석균 ( Suk Kyun Yang ),김정선 ( Jeong Sun Kim ),심기남 ( Ki Nam Shim ),임석아 ( Seock Ah Im ),명승재 ( Seung Jae Myung ),정훈용 ( Hwoon Yong Jung ),유창식 ( Chang Sik Yu ),김진천 ( Jin Cheon Kim ),홍원선 대한소화기학회 2005 대한소화기학회지 Vol.45 No.6
Background/Aims: Lymph node (LN) metastasis occurs in approximately 10% of patients with submucosally invasive colorectal carcinoma. This study was performed to determine the role of matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinase
항응고치료를 받는 환자에서 소화기 영역의 내시경 진단과 치료
정성애 ( Sung Ae Jung ) 대한내과학회 2007 대한내과학회지 Vol.72 No.4
Recently, the treatment of anticoagulant and antiplatelet agents for various cardiovacular and neurologic areas has become popular. Optimal endoscopic approach during the management of the anticoagulant requires consideration for relative risks of thromboembolism and bleeding, but the prospective data are limited. For procedures considered to have a low risk of bleeding such as diagnostic endoscopy or colonoscopy with simple biopsy, it is not necessary to discontinue anticoagulation therapy. For procedure with higher risk of bleeding such as endoscopic polypectomy or mucosal dissection, an individual modification of strategy is required. It should be recognized that the risk of thromboembolic event varies according to the underlying condition when adjustment of anticoagulation is required during endoscopic procedure. (Korean J Med 72:333-339, 2007)
박재정 ( Jae Jung Park ),정성애 ( Sung Ae Jung ),노영욱 ( Young Wook Noh ),강민정 ( Min Jung Kang ),정지민 ( Ji Min Jung ),김성은 ( Seong Eun Kim ),정혜경 ( Hye Kyung Jung ),심기남 ( Ki Nam Shim ),김태헌 ( Tae Hun Kim ),유권 ( Kw 대한소화기학회 2010 대한소화기학회지 Vol.55 No.4
목적: 염증성 장질환에서 골밀도 감소는 비교적 흔한 합병증이며 이와 연관된 위험인자들이 보고되고 있으나, 한국의 염증성 장질환 환자에서의 연구는 미미하다. 본 연구는 염증성 장질환 환자에서의 골밀도 감소의 유병률 및 위험인자를 알아보고자 하였다. 대상 및 방법: 30명의 염증성 장질환 환자를 대상으로 X-선 골밀도 측정기에 의해 골밀도를 측정하였다. 혈청 인, 칼슘, 오스테오칼신과 데옥시피리디놀린을 포함한 인자들을 측정하였다. 의무기록을 후향적으로 검토하여 질병의 유병기간, 활성도, 약물력, 체질량지수 등을 조사하고 골감소와의 연관성을 분석하였다. 결과: 전체 환자의 63.3%에서 골밀도 감소가 있었으며 크론병과 궤양성 대장염에서의 유의한 차이는 없었다. 골밀도 감소와 임상적 지표들 간의 유의한 연관성이 없었고, 골대사의 지표들과 골밀도 사이에 유의한 상관관계가 없었다. 골밀도검사 전 글루코코르티코이드를 사용하지 않았던 염증성 장질환 환자의 50.0%에서 골밀도 감소를 보였다. 결론: 한국의 염증성 장질환 환자에서도 서구와 마찬가지로 골밀도 감소가 빈번하며, 이러한 골감소의 원인은 명확하지는 않지만 다양한 인자들이 복합적으로 관여할 것으로 여겨진다. 따라서, 글루코코르티코이드 사용 여부와 상관없이 염증성 장질환 환자에서 골밀도 측정이 필요하다. Background/Aims: Several clinical risk factors for low bone mineral density (BMD) in the patients with inflammatory bowel disease (IBD) have been suggested. However, its prevalence and pathophysiology in Korean population have not been fully studied. The aim of this study was to investigate the prevalence and risk factors for low BMD in Korean IBD patient. Methods: BMD of the lumbar spine and femur was evaluated using dual-energy X-ray absorptiometry in 30 patients with IBD. Biochemical parameters of bone metabolism, such as serum calcium, phosphorus, osteocalcin, and deoxypyridinoline were measured. The associations between low BMD and clinical parameters such as disease duration, disease activity, drug history, body mass index (BMI), and others were evaluated retrospectively using medical records. Results: Low BMD at the lumbar spine or femur was observed in 63.3% of the patients, and there was no significant difference between the patients with Crohn`s disease and ulcerative colitis. Clinical and biochemical parameters were irrelevant to BMD. In the patients without glucocorticoid treatment prior to BMD measurement, already 50.0% of patients had low BMD. Conclusions: Low BMD is a common feature in Korean IBD patients, even those who do not use glucocorticoid. The multiple factors may be involved in the pathogenesis of low BMD. Therefore, BMD should be examined in all IBD patients, irrespective of glucocorticoid treatment. (Korean J Gastroenterol 2010;55:237-244)
강민정 ( Min Jung Kang ),정성애 ( Sung Ae Jung ),정지민 ( Ji Min Jung ),김성은 ( Seong Eun Kim ),심기남 ( Ki Nam Shim ),정혜경 ( Hye Kyung Jung ),구혜수 ( Hea Soo Koo ),유권 ( Kwon Yoo ),문일환 ( Il Hwan Moon ),정규원 ( Kyu Won C 대한소화기기능성질환·운동학회 2008 Journal of Neurogastroenterology and Motility (JNM Vol.14 No.1
Hypoganglionosis is a rare form of intestinal neuronal malformation, which is characterized by scarce ganglia and a reduced number of parasympathetic nerves in the intestinal wall. Enteric nervous system can be damaged during postnatal period by ischemic, inflammatory, autoimmunologic process or neurotoxic agent. Acquired hypoganglionosis is usually late onset and characterized as degeneration of ganglion cells and gliosis histologically. We report a case of adult type ypoganglionosis, which is assumed to be an acquired type with the review of literature. The patient with a history of chronic constipation and ileus presented with intestinal obstruction and went on surgical management successfully.
Helicobacter pylori 이차 제균에서 Levofloxacin 포함 삼제요법의 효과
정해선 ( Hae Sun Jung ),심기남 ( Ki Nam Shim ),백수정 ( Su Jung Baik ),나윤주 ( Youn Ju Na ),강민정 ( Min Jung Kang ),정지민 ( Ji Min Jung ),하창윤 ( Chang Yoon Ha ),정성애 ( Sung Ae Jung ),유권 ( Kwon Yoo ) 대한소화기학회 2008 대한소화기학회지 Vol.51 No.5
Background/Aims: Bismuth-based quadruple therapy for second-line eradication treatment achieves the eradication rate ranging from 70% to 81% due to antimicrobial resistance and poor compliance. The aim of this study was to compare the eradication rate of levofloxacin-based triple therapy with that of bismuth-based quadruple therapy in second-line Helicobacter pylori (H. pylori) eradication therapy. Methods: Seventy-six outpatients with persistent H. pylori infection after first-line triple therapy were enrolled in this prospective randomized trial. The subjects were randomized to receive levofloxacin 300 mg, amoxicillin 1 g, and pantoprazole 20 mg, given twice daily for 7 days (LAP group), or metronidazole 500 mg twice, tetracycline 500 mg four times, and pantoprazole 20 mg twice, bismuth subcitrate 600 mg twice daily for 7 days (MTPB group). Eradication was confirmed with 13C-urea breath test or rapid urease test 4 weeks after the cessation of therapy. Results: Among Seventy-six patients initially included, eleven were lost during follow-up. The eradication rates, expressed as intention to treat (ITT) and per protocol (PP) analyses, were 51.6% and 53.3% in the LAP group, and 48.9% and 62.9% in the MTPB group, respectively. There was no significant difference in H. pylori eradication rates between the two groups (p=0.815 by ITT, p=0.437 by PP). LAP regimen was better tolerated than MTPB regimen with lower incidence of side effects (10.0% versus 31.4%, p=0.03). Conclusions: H. pylori eradication rates of levofloxacin-based triple therapy and bismuth-based quadruple therapy were not significantly different in second-line H. pylori eradication therapy, and low incidence of side effects was observed in levofloxacin-based triple therapy. (Korean J Gastroenterol 2008;51:285-290)